- Home
- BTCT vs CRIS Comparison
BTCT vs CRIS Comparison
Compare BTCT & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTCT
- CRIS
- Stock Information
- Founded
- BTCT 2006
- CRIS 2000
- Country
- BTCT Singapore
- CRIS United States
- Employees
- BTCT N/A
- CRIS N/A
- Industry
- BTCT Other Consumer Services
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BTCT Real Estate
- CRIS Health Care
- Exchange
- BTCT Nasdaq
- CRIS Nasdaq
- Market Cap
- BTCT 19.8M
- CRIS 21.3M
- IPO Year
- BTCT N/A
- CRIS 2000
- Fundamental
- Price
- BTCT $2.98
- CRIS $2.19
- Analyst Decision
- BTCT
- CRIS Strong Buy
- Analyst Count
- BTCT 0
- CRIS 2
- Target Price
- BTCT N/A
- CRIS $16.50
- AVG Volume (30 Days)
- BTCT 132.3K
- CRIS 76.0K
- Earning Date
- BTCT 08-13-2025
- CRIS 07-31-2025
- Dividend Yield
- BTCT N/A
- CRIS N/A
- EPS Growth
- BTCT N/A
- CRIS N/A
- EPS
- BTCT N/A
- CRIS N/A
- Revenue
- BTCT $11,675,000.00
- CRIS $11,202,000.00
- Revenue This Year
- BTCT $13.58
- CRIS N/A
- Revenue Next Year
- BTCT N/A
- CRIS $10.67
- P/E Ratio
- BTCT N/A
- CRIS N/A
- Revenue Growth
- BTCT 28.68
- CRIS 14.17
- 52 Week Low
- BTCT $1.32
- CRIS $1.02
- 52 Week High
- BTCT $26.58
- CRIS $8.29
- Technical
- Relative Strength Index (RSI)
- BTCT 42.20
- CRIS 50.37
- Support Level
- BTCT $2.75
- CRIS $2.11
- Resistance Level
- BTCT $3.25
- CRIS $2.26
- Average True Range (ATR)
- BTCT 0.21
- CRIS 0.20
- MACD
- BTCT 0.00
- CRIS -0.04
- Stochastic Oscillator
- BTCT 47.30
- CRIS 16.85
About BTCT BTC Digital Ltd.
BTC Digital Ltd is a crypto asset technology company based in the U.S. with a focus on bitcoin mining. The company also generates revenue through mining machine resale and rental business operations. Geographically, the financial assets of the company is located in the United States, Singapore, Hong Kong and the PRC.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.